Zebra Technologies is actively addressing these changes with AI-driven solutions, particularly in retail. (Reuters) Retailers in India are turning to artificial intelligence and real-time data ...

What's interesting about GeneDx's tumble is that its first-quarter performance was, on the surface, rather good. The figures released Wednesday revealed the DNA testing company managed to boost ...

— We have everything you need: full data on over 800 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & ...

The Jewel Patch Wearable Cardioverter Defibrillator. Credit: Element Science/Business Wire. The US Food and Drug Administration (FDA) has approved Element Science’s premarket approval application for ...

GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2025 Earnings Call Transcript April 30, 2025 GeneDx Holdings Corp. beats earnings expectations. Reported EPS is $0.27, expectations were $0.11. Operator: Good ...

GeneDx Holdings Corp reported its earnings for the first quarter of 2025, revealing a significant earnings per share (EPS) miss while surpassing revenue expectations. The company reported an EPS of ...

Genetic testing companies such as GeneDx have made some headway in screening more people of diverse backgrounds, but inequities remain. For example, comprehensive data about cystic fibrosis is ...

Good day, and thank you for standing by. Welcome to the GeneDx First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers ...

Shares of GeneDx Holdings (NASDAQ: WGS) were plunging 42.9% as of 11:21 a.m. ET on Wednesday. The steep decline came after the genetic diagnostics company announced its 2025 first-quarter earnings ...